COVID-19 Impact on Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size, Status and Forecast 2020-2026

August 2020 | 91 pages | ID: CDD29EA7B742EN
QYResearch

Abstracts

This report focuses on the global BCL-2 (B-cell lymphoma 2) Inhibitors status, future forecast, growth opportunity, key market and key players. The study objectives are to present the BCL-2 (B-cell lymphoma 2) Inhibitors development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• AbbVie
• Roche
• Abcam
• Biorbyt
• Biovison
• Tocris Bioscience

Market segment by Type, the product can be split into

• Combination Therapy
• Monotherapy

Market segment by Application, split into

• Positive Lymphoma
• Follicular Lymphoma
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global BCL-2 (B-cell lymphoma 2) Inhibitors status, future forecast, growth opportunity, key market and key players.
• To present the BCL-2 (B-cell lymphoma 2) Inhibitors development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of BCL-2 (B-cell lymphoma 2) Inhibitors are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by BCL-2 (B-cell lymphoma 2) Inhibitors Revenue
1.4 Market Analysis by Type
  1.4.1 Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Combination Therapy
  1.4.3 Monotherapy
1.5 Market by Application
  1.5.1 Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Application: 2020 VS 2026
  1.5.2 Positive Lymphoma
  1.5.3 Follicular Lymphoma
  1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): BCL-2 (B-cell lymphoma 2) Inhibitors Industry Impact
  1.6.1 How the Covid-19 is Affecting the BCL-2 (B-cell lymphoma 2) Inhibitors Industry
    1.6.1.1 BCL-2 (B-cell lymphoma 2) Inhibitors Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and BCL-2 (B-cell lymphoma 2) Inhibitors Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for BCL-2 (B-cell lymphoma 2) Inhibitors Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 BCL-2 (B-cell lymphoma 2) Inhibitors Market Perspective (2015-2026)
2.2 BCL-2 (B-cell lymphoma 2) Inhibitors Growth Trends by Regions
  2.2.1 BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 BCL-2 (B-cell lymphoma 2) Inhibitors Historic Market Share by Regions (2015-2020)
  2.2.3 BCL-2 (B-cell lymphoma 2) Inhibitors Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 BCL-2 (B-cell lymphoma 2) Inhibitors Market Growth Strategy
  2.3.6 Primary Interviews with Key BCL-2 (B-cell lymphoma 2) Inhibitors Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top BCL-2 (B-cell lymphoma 2) Inhibitors Players by Market Size
  3.1.1 Global Top BCL-2 (B-cell lymphoma 2) Inhibitors Players by Revenue (2015-2020)
  3.1.2 Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue Market Share by Players (2015-2020)
  3.1.3 Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Concentration Ratio
  3.2.1 Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by BCL-2 (B-cell lymphoma 2) Inhibitors Revenue in 2019
3.3 BCL-2 (B-cell lymphoma 2) Inhibitors Key Players Head office and Area Served
3.4 Key Players BCL-2 (B-cell lymphoma 2) Inhibitors Product Solution and Service
3.5 Date of Enter into BCL-2 (B-cell lymphoma 2) Inhibitors Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global BCL-2 (B-cell lymphoma 2) Inhibitors Historic Market Size by Type (2015-2020)
4.2 Global BCL-2 (B-cell lymphoma 2) Inhibitors Forecasted Market Size by Type (2021-2026)

5 BCL-2 (B-CELL LYMPHOMA 2) INHIBITORS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2015-2020)
5.2 Global BCL-2 (B-cell lymphoma 2) Inhibitors Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size (2015-2020)
6.2 BCL-2 (B-cell lymphoma 2) Inhibitors Key Players in North America (2019-2020)
6.3 North America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2015-2020)
6.4 North America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe BCL-2 (B-cell lymphoma 2) Inhibitors Market Size (2015-2020)
7.2 BCL-2 (B-cell lymphoma 2) Inhibitors Key Players in Europe (2019-2020)
7.3 Europe BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2015-2020)
7.4 Europe BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2015-2020)

8 CHINA

8.1 China BCL-2 (B-cell lymphoma 2) Inhibitors Market Size (2015-2020)
8.2 BCL-2 (B-cell lymphoma 2) Inhibitors Key Players in China (2019-2020)
8.3 China BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2015-2020)
8.4 China BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan BCL-2 (B-cell lymphoma 2) Inhibitors Market Size (2015-2020)
9.2 BCL-2 (B-cell lymphoma 2) Inhibitors Key Players in Japan (2019-2020)
9.3 Japan BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2015-2020)
9.4 Japan BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia BCL-2 (B-cell lymphoma 2) Inhibitors Market Size (2015-2020)
10.2 BCL-2 (B-cell lymphoma 2) Inhibitors Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2015-2020)
10.4 Southeast Asia BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2015-2020)

11 INDIA

11.1 India BCL-2 (B-cell lymphoma 2) Inhibitors Market Size (2015-2020)
11.2 BCL-2 (B-cell lymphoma 2) Inhibitors Key Players in India (2019-2020)
11.3 India BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2015-2020)
11.4 India BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size (2015-2020)
12.2 BCL-2 (B-cell lymphoma 2) Inhibitors Key Players in Central & South America (2019-2020)
12.3 Central & South America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2015-2020)
12.4 Central & South America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 AbbVie
  13.1.1 AbbVie Company Details
  13.1.2 AbbVie Business Overview and Its Total Revenue
  13.1.3 AbbVie BCL-2 (B-cell lymphoma 2) Inhibitors Introduction
  13.1.4 AbbVie Revenue in BCL-2 (B-cell lymphoma 2) Inhibitors Business (2015-2020))
  13.1.5 AbbVie Recent Development
13.2 Roche
  13.2.1 Roche Company Details
  13.2.2 Roche Business Overview and Its Total Revenue
  13.2.3 Roche BCL-2 (B-cell lymphoma 2) Inhibitors Introduction
  13.2.4 Roche Revenue in BCL-2 (B-cell lymphoma 2) Inhibitors Business (2015-2020)
  13.2.5 Roche Recent Development
13.3 Abcam
  13.3.1 Abcam Company Details
  13.3.2 Abcam Business Overview and Its Total Revenue
  13.3.3 Abcam BCL-2 (B-cell lymphoma 2) Inhibitors Introduction
  13.3.4 Abcam Revenue in BCL-2 (B-cell lymphoma 2) Inhibitors Business (2015-2020)
  13.3.5 Abcam Recent Development
13.4 Biorbyt
  13.4.1 Biorbyt Company Details
  13.4.2 Biorbyt Business Overview and Its Total Revenue
  13.4.3 Biorbyt BCL-2 (B-cell lymphoma 2) Inhibitors Introduction
  13.4.4 Biorbyt Revenue in BCL-2 (B-cell lymphoma 2) Inhibitors Business (2015-2020)
  13.4.5 Biorbyt Recent Development
13.5 Biovison
  13.5.1 Biovison Company Details
  13.5.2 Biovison Business Overview and Its Total Revenue
  13.5.3 Biovison BCL-2 (B-cell lymphoma 2) Inhibitors Introduction
  13.5.4 Biovison Revenue in BCL-2 (B-cell lymphoma 2) Inhibitors Business (2015-2020)
  13.5.5 Biovison Recent Development
13.6 Tocris Bioscience
  13.6.1 Tocris Bioscience Company Details
  13.6.2 Tocris Bioscience Business Overview and Its Total Revenue
  13.6.3 Tocris Bioscience BCL-2 (B-cell lymphoma 2) Inhibitors Introduction
  13.6.4 Tocris Bioscience Revenue in BCL-2 (B-cell lymphoma 2) Inhibitors Business (2015-2020)
  13.6.5 Tocris Bioscience Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. BCL-2 (B-cell lymphoma 2) Inhibitors Key Market Segments
Table 2. Key Players Covered: Ranking by BCL-2 (B-cell lymphoma 2) Inhibitors Revenue
Table 3. Ranking of Global Top BCL-2 (B-cell lymphoma 2) Inhibitors Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Combination Therapy
Table 6. Key Players of Monotherapy
Table 7. COVID-19 Impact Global Market: (Four BCL-2 (B-cell lymphoma 2) Inhibitors Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for BCL-2 (B-cell lymphoma 2) Inhibitors Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for BCL-2 (B-cell lymphoma 2) Inhibitors Players to Combat Covid-19 Impact
Table 12. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Regions (2015-2020)
Table 16. Global BCL-2 (B-cell lymphoma 2) Inhibitors Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. BCL-2 (B-cell lymphoma 2) Inhibitors Market Growth Strategy
Table 22. Main Points Interviewed from Key BCL-2 (B-cell lymphoma 2) Inhibitors Players
Table 23. Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue by Players (2015-2020) (Million US$)
Table 24. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Players (2015-2020)
Table 25. Global Top BCL-2 (B-cell lymphoma 2) Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in BCL-2 (B-cell lymphoma 2) Inhibitors as of 2019)
Table 26. Global BCL-2 (B-cell lymphoma 2) Inhibitors by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players BCL-2 (B-cell lymphoma 2) Inhibitors Product Solution and Service
Table 29. Date of Enter into BCL-2 (B-cell lymphoma 2) Inhibitors Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 32. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size Share by Type (2015-2020)
Table 33. Global BCL-2 (B-cell lymphoma 2) Inhibitors Revenue Market Share by Type (2021-2026)
Table 34. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size Share by Application (2015-2020)
Table 35. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 36. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size Share by Application (2021-2026)
Table 37. North America Key Players BCL-2 (B-cell lymphoma 2) Inhibitors Revenue (2019-2020) (Million US$)
Table 38. North America Key Players BCL-2 (B-cell lymphoma 2) Inhibitors Market Share (2019-2020)
Table 39. North America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 40. North America BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Type (2015-2020)
Table 41. North America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 42. North America BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Application (2015-2020)
Table 43. Europe Key Players BCL-2 (B-cell lymphoma 2) Inhibitors Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players BCL-2 (B-cell lymphoma 2) Inhibitors Market Share (2019-2020)
Table 45. Europe BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 46. Europe BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Type (2015-2020)
Table 47. Europe BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 48. Europe BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Application (2015-2020)
Table 49. China Key Players BCL-2 (B-cell lymphoma 2) Inhibitors Revenue (2019-2020) (Million US$)
Table 50. China Key Players BCL-2 (B-cell lymphoma 2) Inhibitors Market Share (2019-2020)
Table 51. China BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 52. China BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Type (2015-2020)
Table 53. China BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 54. China BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Application (2015-2020)
Table 55. Japan Key Players BCL-2 (B-cell lymphoma 2) Inhibitors Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players BCL-2 (B-cell lymphoma 2) Inhibitors Market Share (2019-2020)
Table 57. Japan BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 58. Japan BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Type (2015-2020)
Table 59. Japan BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 60. Japan BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players BCL-2 (B-cell lymphoma 2) Inhibitors Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players BCL-2 (B-cell lymphoma 2) Inhibitors Market Share (2019-2020)
Table 63. Southeast Asia BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Type (2015-2020)
Table 65. Southeast Asia BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Application (2015-2020)
Table 67. India Key Players BCL-2 (B-cell lymphoma 2) Inhibitors Revenue (2019-2020) (Million US$)
Table 68. India Key Players BCL-2 (B-cell lymphoma 2) Inhibitors Market Share (2019-2020)
Table 69. India BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 70. India BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Type (2015-2020)
Table 71. India BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 72. India BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Application (2015-2020)
Table 73. Central & South America Key Players BCL-2 (B-cell lymphoma 2) Inhibitors Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players BCL-2 (B-cell lymphoma 2) Inhibitors Market Share (2019-2020)
Table 75. Central & South America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Type (2015-2020)
Table 77. Central & South America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Application (2015-2020)
Table 79. AbbVie Company Details
Table 80. AbbVie Business Overview
Table 81. AbbVie Product
Table 82. AbbVie Revenue in BCL-2 (B-cell lymphoma 2) Inhibitors Business (2015-2020) (Million US$)
Table 83. AbbVie Recent Development
Table 84. Roche Company Details
Table 85. Roche Business Overview
Table 86. Roche Product
Table 87. Roche Revenue in BCL-2 (B-cell lymphoma 2) Inhibitors Business (2015-2020) (Million US$)
Table 88. Roche Recent Development
Table 89. Abcam Company Details
Table 90. Abcam Business Overview
Table 91. Abcam Product
Table 92. Abcam Revenue in BCL-2 (B-cell lymphoma 2) Inhibitors Business (2015-2020) (Million US$)
Table 93. Abcam Recent Development
Table 94. Biorbyt Company Details
Table 95. Biorbyt Business Overview
Table 96. Biorbyt Product
Table 97. Biorbyt Revenue in BCL-2 (B-cell lymphoma 2) Inhibitors Business (2015-2020) (Million US$)
Table 98. Biorbyt Recent Development
Table 99. Biovison Company Details
Table 100. Biovison Business Overview
Table 101. Biovison Product
Table 102. Biovison Revenue in BCL-2 (B-cell lymphoma 2) Inhibitors Business (2015-2020) (Million US$)
Table 103. Biovison Recent Development
Table 104. Tocris Bioscience Company Details
Table 105. Tocris Bioscience Business Overview
Table 106. Tocris Bioscience Product
Table 107. Tocris Bioscience Revenue in BCL-2 (B-cell lymphoma 2) Inhibitors Business (2015-2020) (Million US$)
Table 108. Tocris Bioscience Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Type: 2020 VS 2026
Figure 2. Combination Therapy Features
Figure 3. Monotherapy Features
Figure 4. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Application: 2020 VS 2026
Figure 5. Positive Lymphoma Case Studies
Figure 6. Follicular Lymphoma Case Studies
Figure 7. Others Case Studies
Figure 8. BCL-2 (B-cell lymphoma 2) Inhibitors Report Years Considered
Figure 9. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Regions: 2020 VS 2026
Figure 11. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global BCL-2 (B-cell lymphoma 2) Inhibitors Market Share by Players in 2019
Figure 14. Global Top BCL-2 (B-cell lymphoma 2) Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in BCL-2 (B-cell lymphoma 2) Inhibitors as of 2019
Figure 15. The Top 10 and 5 Players Market Share by BCL-2 (B-cell lymphoma 2) Inhibitors Revenue in 2019
Figure 16. North America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe BCL-2 (B-cell lymphoma 2) Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China BCL-2 (B-cell lymphoma 2) Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan BCL-2 (B-cell lymphoma 2) Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia BCL-2 (B-cell lymphoma 2) Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India BCL-2 (B-cell lymphoma 2) Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America BCL-2 (B-cell lymphoma 2) Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018
Figure 24. AbbVie Revenue Growth Rate in BCL-2 (B-cell lymphoma 2) Inhibitors Business (2015-2020)
Figure 25. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. Roche Revenue Growth Rate in BCL-2 (B-cell lymphoma 2) Inhibitors Business (2015-2020)
Figure 27. Abcam Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Abcam Revenue Growth Rate in BCL-2 (B-cell lymphoma 2) Inhibitors Business (2015-2020)
Figure 29. Biorbyt Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Biorbyt Revenue Growth Rate in BCL-2 (B-cell lymphoma 2) Inhibitors Business (2015-2020)
Figure 31. Biovison Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Biovison Revenue Growth Rate in BCL-2 (B-cell lymphoma 2) Inhibitors Business (2015-2020)
Figure 33. Tocris Bioscience Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Tocris Bioscience Revenue Growth Rate in BCL-2 (B-cell lymphoma 2) Inhibitors Business (2015-2020)
Figure 35. Bottom-up and Top-down Approaches for This Report
Figure 36. Data Triangulation
Figure 37. Key Executives Interviewed